8-TETRAHYDROCANNABINOL(5957-75-5)'s Uses,Safety,Toxicity,Consensus,History,Production,AnalyticalMethods,Standards, 1-trans-Δ8-TETRAHYDROCANNABINOL(5957-75-5)'s manufactures, suppliers,Synthesis,1-trans-Δ8-TETRAHYDROCANNABINOL" /> 8-TETRAHYDROCANNABINOLfor price inquiry.where to buy 1-trans-Δ8-TETRAHYDROCANNABINOL.Also offer free database of 1-trans-Δ8-TETRAHYDROCANNABINOL including MSDS sheet(poisoning, toxicity, hazards and safety),chemical properties,Formula, density and structure, solution etc." />
Basic Information | Post buying leads | 8-TETRAHYDROCANNABINOL" target="_blank" rel="nofollow">Suppliers | Cas Database |
Name |
8-TETRAHYDROCANNABINOL">1-trans-Δ8-TETRAHYDROCANNABINOL |
EINECS | 200-659-6 |
CAS No. | 5957-75-5 | Density | 1.015 g/cm3 |
PSA | 29.46000 | LogP | 5.73580 |
Solubility | N/A | Melting Point |
N/A |
Formula | C21H30 O2 | Boiling Point | 383.5 °C at 760 mmHg |
Molecular Weight | 314.468 | Flash Point | 144.5 °C |
Transport Information | UN 1170 | Appearance | N/A |
Safety | Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. Human mutation data reported. An hallucinatory drug. When heated to decomposition it emits acrid smoke and irritating fumes. See also CANNABIS. | Risk Codes | 11-39/23/24/25-23/24/25 |
Molecular Structure | Hazard Symbols | F | |
Synonyms |
6H-Dibenzo[b,d]pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-;6H-Dibenzo[b,d]pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-,trans-(-)- (8CI); (-)-trans-D8-Tetrahydrocannabinol; (-)-D6-Tetrahydrocannabinol; (-)-D8-6a,10a-trans-Tetrahydrocannabinol; (-)-D8-THC; (-)-D8-Tetrahydrocannabinol; (-)-D8-trans-Tetrahydrocannabinol;Cannabinol, D1(6)-tetrahydro-;NSC 134453; l-D8-Tetrahydrocannabinol;trans-D8-Tetrahydrocannabinol; D1(6)-Tetrahydrocannabinol; D1(6)-trans-Tetrahydrocannabinol; D6-Tetrahydrocannabinol; D8-THC; D8-Tetrahydrocannabinol; D8-l-Tetrahydrocannabinol; D8-trans-Tetrahydrocannabinol |
Article Data | 4 |
IUPAC Name: Tetrahydrocannabinols (-)-delta6-3,4-trans-form
The MF of Tetrahydrocannabinols (-)-delta6-3,4-trans-form (5957-75-5) is C21H30O2.
The MW of Tetrahydrocannabinols (-)-delta6-3,4-trans-form (5957-75-5) is 314.46.
Synonyms of Tetrahydrocannabinols (-)-delta6-3,4-trans-form (5957-75-5): (-)-Delta(sup6)-3,4-trans-tetrahydrocannabinol ; (-)-Delta(sup8)-trans-tetrahydrocannabinol ; (-)-Trans-delta(sup8)-tetrahydrocannabinol ; 1-Trans-delta(sup8)-tetrahydro-cannabino;1-trans-delta(sup8)-tetrahydrocannabinol ; D)Pyran-1-ol,6a,7,10,10a-tetrahydro-3-pentyl-6,6,9-trimethyl-6h-dibenzo(tr ; D)Pyran-1-ol,6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6h-dibenzo(;delta(sup6)-thc
Index of Refraction: 1.528
Density: 1.015 g/ml
Flash Point: 144.5 °C
Boiling Point: 383.5 °C
Storage temp: -20 °C
Form: ethanol solution
Tetrahydrocannabinols (-)-delta6-3,4-trans-form (5957-75-5) is used as organic synthesis, pharmaceutical intermediate.
1. | dni-hmn:hla 10 µmol/L | ANTRD4 Anticancer Research. 3 (1983),211. | ||
2. | oms-mus-ipr 200 mg/kg | RCOCB8 Research Communications in Chemical Pathology and Pharmacology. 17 (1977),703. | ||
3. | orl-rat LD50:860 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 25 (1973),363. | ||
4. | ipr-rat LD50:560 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133. | ||
5. | ivn-rat LD50:97 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133. | ||
6. | ipr-mus LD50:210 mg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 196 (1972),133. | ||
7. | ivn-mus LD50:27,500 µg/kg | JMCMAR Journal of Medicinal Chemistry. 21 (1978),1079. |
EPA Genetic Toxicology Program.
Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. Human mutation data reported. An hallucinatory drug. When heated to decomposition it emits acrid smoke and irritating fumes. See also CANNABIS.Safety information of Tetrahydrocannabinols (-)-delta6-3,4-trans-form (5957-75-5):
Hazard Codes F
Risk Statements
11 Highly Flammable
39/23/24/25 Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed
Safety Statements
7 Keep container tightly closed
16 Keep away from sources of ignition - No smoking
36/37 Wear suitable protective clothing and gloves
45 In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
RIDADR UN 1170 3/PG 2